A peritoneal dialysis solution prepared from a three-compartment bag: biological and clinical effects.
Cappelli
G
G
Osp. Villa Scassi, Genova, Italy. giocap@tin.it
Amore
A
A
Bandiani
G
G
Cancarini
G
G
Coppo
R
R
Feriani
M
M
Dell'Aquila
R
R
Saffioti
S
S
Spisni
C
C
Stingone
A
A
Orazi
E
E
Ballocchi
S
S
Renaux
J L
JL
D000368:Aged; D017209:Apoptosis / Q000187:drug effects; D053453:Caspase 9; D020169:Caspases / Q000032:analysis; D002478:Cells, Cultured; D015314:Dialysis Solutions / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology*; D004349:Drug Packaging / Q000295:instrumentation*; D004356:Drug Storage; D004573:Electrolytes / Q000008:administration & dosage / Q000737:chemistry; D004848:Epithelium / Q000737:chemistry / Q000187:drug effects*; D004867:Equipment Design; D005260:Female; D005947:Glucose / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D017127:Glycation End Products, Advanced / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology*; D006031:Glycosylation; D006801:Humans; D020287:In Situ Nick-End Labeling; D008297:Male; D008565:Membrane Proteins / Q000737:chemistry / Q000187:drug effects; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D010537:Peritoneum / Q000737:chemistry / Q000166:cytology / Q000187:drug effects*; D016159:Tumor Suppressor Protein p53 / Q000032:analysis; D014511:Uremia / Q000097:blood / Q000628:therapy*
D015314:Dialysis Solutions; D004573:Electrolytes; D017127:Glycation End Products, Advanced; D008565:Membrane Proteins; D016159:Tumor Suppressor Protein p53; C506433:CASP9 protein, human; D053453:Caspase 9; D020169:Caspases; D005947:Glucose